Piper Jaffray Initiates Coverage on Obagi Medical Products (OMPI) with an Overweight; Attractive at Current Levels
Tweet Send to a Friend
Piper Jaffray & Co. initiates coverage on Obagi Medical Products (Nasdaq: OMPI) with an Overweight. Price target $9.
Piper analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
